Pfizer Inc
General ticker "PFE" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $146.0B
Pfizer Inc follows the US Stock Market performance with the rate: 1.0%.
Estimated limits based on current volatility of 1.1%: low 26.19$, high 26.78$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-11-08, amount 0.42$ (Y6.28%)
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [20.84$, 34.49$]
- 2024-12-30 to 2025-12-30 estimated range: [22.03$, 35.90$]
Financial Metrics affecting the PFE estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 1.83
- Positive: 1.03 < Operating profit margin, % of 5.74
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 0.94
- Positive: Industry inventory ratio change (median), % of -2.41 <= -0.39
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Positive: 2.35 < Operating cash flow per share per price, % of 5.41
Short-term PFE quotes
Long-term PFE plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $86,166.00MM | $100,113.00MM | $58,496.00MM |
| Operating Expenses | $61,855.00MM | $65,386.00MM | $55,137.00MM |
| Operating Income | $24,311.00MM | $34,727.00MM | $3,359.00MM |
| Non-Operating Income | $0.00MM | $2.00MM | $-2,301.00MM |
| Interest Expense | $1,291.00MM | $1,238.00MM | $2,209.00MM |
| R&D Expense | $13,829.00MM | $11,428.00MM | $10,679.00MM |
| Income(Loss) | $24,311.00MM | $34,729.00MM | $1,058.00MM |
| Taxes | $1,852.00MM | $3,328.00MM | $-1,115.00MM |
| Other Income(Loss) | $-434.00MM | $6.00MM | $-15.00MM |
| Profit(Loss) | $22,025.00MM | $31,407.00MM | $2,158.00MM |
| Stockholders Equity | $77,201.00MM | $95,661.00MM | $89,014.00MM |
| Inventory | $9,059.00MM | $8,981.00MM | $10,189.00MM |
| Assets | $181,476.00MM | $197,205.00MM | $226,501.00MM |
| Operating Cash Flow | $32,580.00MM | $29,267.00MM | $8,700.00MM |
| Capital expenditure | $2,711.00MM | $3,236.00MM | $3,907.00MM |
| Investing Cash Flow | $-22,546.00MM | $-15,783.00MM | $-32,278.00MM |
| Financing Cash Flow | $-9,816.00MM | $-14,834.00MM | $26,066.00MM |
| Earnings Per Share* | $3.95 | $5.59 | $0.38 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.